Shanghai Hongyu Medical Technology Co.,Ltd, founded in 2019, the registered capital of 10 million yuan, is the world's first pet dogs mitral valve regurgitation involvement in medical equipment research and development of the company. The core product is V-Clamp, a self-developed mitral valve interventional repair device. The technology of the product comes from the parent company Shanghai Hanyu Medical Technology Co., Ltd., which is a global leader. In 2020, CITIC fund and Lize capital will lead the investment to complete round a financing of RMB 30 million. Nearly ten thousand square meters R & D base and factory building are located in Hangzhou and will be started soon. The company adheres to the concept of innovation and development, takes the benefit of pet life as its mission, and strives to become a global leader in pet heart disease treatment.